Gynecologic health care for females with cystic fibrosis

As females with cystic fibrosis (CF) increasingly reach their reproductive years, gynecologic issues have become an important area of clinical care and research. First, females with CF may have disease-specific gynecologic problems, including cyclic pulmonary symptoms, vaginal yeast infections, and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andrea H. Roe, Lina Merjaneh, Rachael Oxman, Kara S. Hughan
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/fa4cdc81ecd143019bc1a80f3038eff6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa4cdc81ecd143019bc1a80f3038eff6
record_format dspace
spelling oai:doaj.org-article:fa4cdc81ecd143019bc1a80f3038eff62021-11-20T05:06:26ZGynecologic health care for females with cystic fibrosis2214-623710.1016/j.jcte.2021.100277https://doaj.org/article/fa4cdc81ecd143019bc1a80f3038eff62021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2214623721000296https://doaj.org/toc/2214-6237As females with cystic fibrosis (CF) increasingly reach their reproductive years, gynecologic issues have become an important area of clinical care and research. First, females with CF may have disease-specific gynecologic problems, including cyclic pulmonary symptoms, vaginal yeast infections, and urinary incontinence. Next, contraceptive methods are thought to be overall safe and effective, however further research is needed to confirm this and to understand the lower rates of uptake among females with CF compared to the general population. Further, females with CF have reduced fertility, although the etiology of this is unknown and under investigation. While assisted reproductive technologies may help achieve pregnancy, decision-making around parenthood remains complex. Finally, while patients and providers agree on the importance of sexual and reproductive health care, females with CF underutilize basic preventive services such as cervical cancer screening, and better approaches are needed to bridge the gap with gynecology. In this review, we discuss the current state of gynecologic care for females with CF, as well as clinical and research opportunities for improvement.Andrea H. RoeLina MerjanehRachael OxmanKara S. HughanElsevierarticleCystic fibrosisGynecologySexual healthReproductive healthMenstrualContraceptionDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENJournal of Clinical & Translational Endocrinology, Vol 26, Iss , Pp 100277- (2021)
institution DOAJ
collection DOAJ
language EN
topic Cystic fibrosis
Gynecology
Sexual health
Reproductive health
Menstrual
Contraception
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle Cystic fibrosis
Gynecology
Sexual health
Reproductive health
Menstrual
Contraception
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Andrea H. Roe
Lina Merjaneh
Rachael Oxman
Kara S. Hughan
Gynecologic health care for females with cystic fibrosis
description As females with cystic fibrosis (CF) increasingly reach their reproductive years, gynecologic issues have become an important area of clinical care and research. First, females with CF may have disease-specific gynecologic problems, including cyclic pulmonary symptoms, vaginal yeast infections, and urinary incontinence. Next, contraceptive methods are thought to be overall safe and effective, however further research is needed to confirm this and to understand the lower rates of uptake among females with CF compared to the general population. Further, females with CF have reduced fertility, although the etiology of this is unknown and under investigation. While assisted reproductive technologies may help achieve pregnancy, decision-making around parenthood remains complex. Finally, while patients and providers agree on the importance of sexual and reproductive health care, females with CF underutilize basic preventive services such as cervical cancer screening, and better approaches are needed to bridge the gap with gynecology. In this review, we discuss the current state of gynecologic care for females with CF, as well as clinical and research opportunities for improvement.
format article
author Andrea H. Roe
Lina Merjaneh
Rachael Oxman
Kara S. Hughan
author_facet Andrea H. Roe
Lina Merjaneh
Rachael Oxman
Kara S. Hughan
author_sort Andrea H. Roe
title Gynecologic health care for females with cystic fibrosis
title_short Gynecologic health care for females with cystic fibrosis
title_full Gynecologic health care for females with cystic fibrosis
title_fullStr Gynecologic health care for females with cystic fibrosis
title_full_unstemmed Gynecologic health care for females with cystic fibrosis
title_sort gynecologic health care for females with cystic fibrosis
publisher Elsevier
publishDate 2021
url https://doaj.org/article/fa4cdc81ecd143019bc1a80f3038eff6
work_keys_str_mv AT andreahroe gynecologichealthcareforfemaleswithcysticfibrosis
AT linamerjaneh gynecologichealthcareforfemaleswithcysticfibrosis
AT rachaeloxman gynecologichealthcareforfemaleswithcysticfibrosis
AT karashughan gynecologichealthcareforfemaleswithcysticfibrosis
_version_ 1718419635394576384